Lipid Headgroup Discrimination by Antimicrobial Peptide LL-37: Insight into Mechanism of Action  by Neville, Frances et al.
Lipid Headgroup Discrimination by Antimicrobial Peptide LL-37:
Insight into Mechanism of Action
Frances Neville,* Marjolaine Cahuzac,* Oleg Konovalov,y Yuji Ishitsuka,z Ka Yee C. Lee,z
Ivan Kuzmenko,§ Girish M. Kale,* and David Gidalevitz{
*Institute for Materials Research, University of Leeds, Leeds, United Kingdom; yEuropean Synchrotron Radiation Facility, Grenoble,
France; zDepartment of Chemistry, The Institute for Biophysical Dynamics and The James Franck Institute, The University of Chicago,
Chicago, Illinois; §Advanced Photon Source, Argonne National Laboratory, Argonne, Illinois; and {Department of Chemical
Engineering, Illinois Institute of Technology, Chicago, Illinois
ABSTRACT Interaction of the human antimicrobial peptide LL-37 with lipid monolayers has been investigated by a range of
complementary techniques including pressure-area isotherms, insertion assay, epiﬂuorescence microscopy, and synchrotron
x-ray scattering, to analyze its mechanism of action. Lipid monolayers were formed at the air-liquid interface to mimic the
surface of the bacterial cell wall and the outer leaﬂet of erythrocyte cell membrane by using phosphatidylglycerol (DPPG),
phosphatidylcholine (DPPC), and phosphatidylethanolamine (DPPE) lipids. LL-37 is found to readily insert into DPPG mono-
layers, disrupting their structure and thus indicating bactericidal action. In contrast, DPPC and DPPE monolayers remained
virtually unaffected by LL-37, demonstrating its nonhemolytic activity and lipid discrimination. Specular x-ray reﬂectivity data
yielded considerable differences in layer thickness and electron-density proﬁle after addition of the peptide to DPPG mono-
layers, but little change was seen after peptide injection when probing monolayers composed of DPPC and DPPE. Grazing
incidence x-ray diffraction demonstrated signiﬁcant peptide insertion and lateral packing order disruption of the DPPG mono-
layer by LL-37 insertion. Epiﬂuorescence microscopy data support these ﬁndings.
INTRODUCTION
A worldwide increase in multidrug-resistant bacteria (1–4)
has made it imperative to develop new classes of antibiotics.
Certain antimicrobial peptides of the innate immune system
can distinguish membranes having different lipid composi-
tions (5–9). This property allows them to lyse bacterial mem-
branes while leaving eukaryotic plasma membranes unaltered.
A better understanding of this ability at a molecular level
could enhance the design and development of antimicrobial
peptides as alternatives to the conventional antibiotics used
today.
During the last decade it has been established that anti-
microbial peptides act by permeating cell membranes (7,10–12).
Two main mechanisms of action of membrane perturbation
by antimicrobial peptides have been previously proposed:
the barrel stave model (13–17) and the carpet model (11,12,
18–22).
In the barrel stave mechanism, peptide monomers bind to
the lipid membrane and then assemble together to form
bundles, in which the hydrophobic surfaces interact with the
acyl chain part of the membrane. The hydrophilic regions
align together to form a pore which may be increased in size
by additional peptide monomers.
In the carpet model, peptides bind to the outside of the
membrane by adsorption to the headgroup region of the lipid
membrane, carpeting the surface of the membrane and ori-
enting parallel to it. Membrane disruption may occur due to
the formation of pores in the membrane or via membrane
micellization. When a critical peptide/lipid ratio is reached,
the peptides are thought to change orientation to a direction
perpendicular to the membrane (23). It is these reorientated
peptides that can then form the toroidal pores (7,22–24). The
formation of toroidal pores may then be followed by the com-
plete collapse of the membrane.
It has been proposed that human antimicrobial peptide
LL-37 (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVP-
RTES-NH2) acts by perturbing membranes via the carpet
mechanism of action (19,25,26). Oren et al. (19) suggest that
LL-37 carpets the surface of both zwitterionic phosphatidyl-
choline (PC) and negatively charged PC/phosphatidylserine
(PS) vesicles. They suggest that LL-37 oligomerizes in
solution, and although it is self-associated when bound to
zwitterionic phospholipid vesicles, it dissociates into mono-
mers upon binding to negatively charged vesicles. Henzler-
Wildman et al. (25,26) also demonstrate that LL-37 ﬁrst
carpets lipid bilayers before membrane perturbation by using
solid-state nuclear magnetic resonance and differential scan-
ning calorimetry experiments. Their results support the carpet
mechanism of action of lipid bilayer disruption by LL-37.
One of the most important stages of peptide-membrane
interaction is an initial contact of the peptide with the outer
leaﬂet of the plasma membrane. To investigate what deﬁnes
the propensity of peptides to interact with speciﬁc membrane
lipids, methods that allow the membrane to be modeled in
a ﬂuid environment are needed. One such approach is the use
of a Langmuir monolayer to mimic the external leaﬂet of the
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cell membrane, coupled with the introduction of peptides
into the subphase of a Langmuir trough to represent the ex-
tracellular ﬂuid and thus the approach of the peptide toward
the cell surface. Different lipid compositions can be used to
represent the membranes of different cell types, and changes
in membrane structure resulting from its interaction with
peptides allow us to suggest a possible mechanism of peptide
action.
The outer leaﬂet of mammalian cell membranes mainly
comprises PC, phosphatidylethanolamine (PE), sphingomye-
lin, and cholesterol, which are charge-neutral at physiolog-
ical pH.
In this work, we used dipalmitoylphosphatidylcholine
(DPPC) and dipalmitoylphosphatidylethanolamine (DPPE)
to study the interaction of LL-37 with the human red blood
cell membrane. Nouri-Sorkhabi et al. (27) used P-31 NMR
spectra of human erythrocyte lysates to ﬁnd that PE accounts
for 33.3% and PC makes up ;30.3% of human erythrocyte
membrane mass. Independently, Keller et al. (28) found that
human red blood cell membrane contains on average ;34%
PE and 35% PC, although their distribution among the leaﬂets
is asymmetrical: the majority of PC (;28% total lipid con-
tent) is at the outer leaﬂet, whereas the majority of PE
(;28% total lipid content) is within the inner leaﬂet.
The surfaces of both Gram-negative and Gram-positive
bacterial cell walls contain large amounts of negatively charged
lipids (29,30). The outer layer of Gram-positive bacteria cell
wall is composed of acidic polysaccharides (teichoic acids)
and phosphatidylglycerol (PG) (31), whereas the outer leaﬂet
of the outer membrane bilayer of the Gram-negative bacteria
is predominantly composed of lipopolysaccharide (LPS), a
polyanionic molecule (29,30,32–34).
In this article, we look into the interaction of LL-37 with
DPPG lipid. In a consequent article (F. Neville, C. S.
Hodges, C. Liu, O. Konovalov, and D. Gidalevitz, unpub-
lished), we use lipid A, the main lipid component of
lipopolysaccharides, to study Gram-negative membrane
lysis by LL-37, protegrin-1, and SMAP-29 antimicrobial
peptides.
A similar approach has been successfully used in conjunc-
tion with x-ray surface scattering and epiﬂuorescence tech-
niques to study interactions of phospholipid monolayers
with the porcine antimicrobial peptide protegrin-1 (35).
Surface x-ray scattering techniques yield information about
the packing arrangement of the lipid layer before and
after introduction of antimicrobial peptide into the system,
whereas epiﬂuorescence microscopy allows direct observa-
tion of the changes in lipid monolayer morphology caused
by peptides. Langmuir monolayer techniques and surface
x-ray scattering have also been successfully applied to study
interactions of an amphibian antimicrobial peptide, PGLa
(9). More recently, preliminary studies on the human
antimicrobial peptide LL-37 using electrochemical tech-
niques and epiﬂuorescence microscopy have been carried
out (36).
In this article, the interaction of LL-37 with phospholipid
monolayers is further studied using a combination of pres-
sure area isotherms, specular x-ray reﬂectivity (XR), grazing
incidence x-ray diffraction (GIXD), and epiﬂuorescence
microscopy (EFM) in a complementary manner, with the
purpose of probing the question of antimicrobial peptide
selectivity between prokaryotic and eukaryotic cells and its
possible mechanism of action. Discrimination of LL-37
between monolayers modeling outer layers of red blood cells
and bacterial membranes has been demonstrated. Although
no interactions of LL-37 with DPPC or DPPE monolayers
were observed, signiﬁcant insertion of LL-37 into DPPG
monolayers was documented with each of the experimental
techniques used. The mechanism of LL-37 insertion into




To study peptide-membrane interactions, Langmuir monolayers composed
of lipids representative of membranes were studied. This approach has been
utilized repeatedly over the years (37–43). The planar monolayer system
allows versatile adjustments of parameters such as monolayer composition,
surface pressure, packing density, temperature, and aqueous subphase con-
dition to model the conditions under which peptides approach the outer
surface of the membrane from the extracellular medium. The cell mem-
branes of different organisms have characteristic lipid compositions.
However, to develop a full understanding of membrane interactions, each
component of a membrane should be studied separately to ascertain the
contribution of each membrane component to the overall interaction of the
peptide with the membrane. DPPC, DPPE, and dipalmitoylphosphatidyl-
glycerol (DPPG) were used to form Langmuir monolayers. All lipids were
purchased from Avanti Polar Lipids (Alabaster, AL) and were used without
further puriﬁcation.
Pressure-area compression isotherms
All experiments were performed using Dulbecco’s phosphate buffered saline
(DPBS) (Invitrogen, Carlsbad, CA) without calcium and magnesium ions.
Monolayers of DPPC and DPPE were deposited from chloroform (high-
performance liquid chromatography grade, Fisher Scientiﬁc, Pittsburgh, PA)
solution, whereas DPPGwas deposited from 9:1 v/v % chloroform/methanol
solution (high-performance liquid chromatography grade, Fisher Scientiﬁc).
Upon spreading, the lipid ﬁlm was left undisturbed for 15 min to allow for
solvent evaporation. At this point, barrier compression was initiated and the
increase in surface pressure of the monolayer was monitored. This gives rise
to a surface pressure (mN/m) versus area per lipid molecule (A˚2/molecule)
isotherm, which can be utilized to deduce the phases and phase transitions
associated with the monolayer as a function of lateral lipid packing density.
Insertion experiments
Insertion experiments were carried out to quantify the interaction of LL-37
with the lipid monolayer. Initially, the lipid monolayer was deposited and
equilibrated, followed by compression to the surface pressure corresponding
to the liquid-condensed phase of lipids (30–40 mN/m), and equivalent to the
packing density of the cell membrane (44,45). The surface pressure was kept
constant via a built-in proportional-integral-derivative control feedback
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system by adjusting the surface area. The LL-37 solution (10 mg/ml LL-37
in 0.01% glacial acetic acid w/v) was then evenly injected underneath the
monolayer using a microsyringe with an L-shaped needle (VDRL needle;
Hamilton, Reno, NV) to make up the ﬁnal concentration of 0.04 mg/ml or
0.1 mg/ml. The surface pressure immediately increased as a result of peptide
incorporation into the lipid monolayer. Injected peptides interact with the
lipid monolayer and result in an increase in the surface pressure. To keep
the surface pressure constant, the surface area would have to increase. The
resulting relative change in area per molecule,DA/A, was monitored through-
out the experiment to compare the degree of LL-37 insertion into DPPC,
DPPE, and DPPG monolayers. Epiﬂuorescence microscopy was used con-
currently with insertion experiments to monitor the surface morphology of
the monolayers on insertion of LL-37; this involved the incorporation of a
small amount of ﬂuorescent dye into the different lipid-spreading solutions.
LL-37 at the interface
LL-37 (90–95% pure) was supplied by Pepceuticals (Nottingham, UK). LL-
37 peptide was provided as a solid powder and made up to a working
solution (10 mg/ml LL-37 in 0.01% glacial acetic acid w/v). Acetic acid was
used to maintain the peptide structure while in solution. LL-37 is soluble in
water, but, being amphipathic (46), is expected to be adsorbed at the air-
liquid interface. LL-37 was injected into the pure subphase without a lipid
monolayer present. The properties of pure LL-37 monolayer were then
investigated using pressure-area isotherms in conjunction with x-ray reﬂec-
tivity and grazing incidence x-ray diffraction.
Langmuir troughs
Pressure-area compression isotherms were performed using a twin-barrier
rectangular Teﬂon micro Langmuir-Blodgett trough equipped with a Wil-
helmy plate (Nima Technology, Coventry, UK). Insertion experiment data
presented here were obtained using a custom-built trough (35,47) at the
University of Chicago. X-ray scattering measurements were taken at the
European Synchrotron Radiation Facility (ESRF) (9) and Advanced Photon
Source (APS) synchrotrons, both of which utilizing custom-built Langmuir
troughs equipped with a single moveable barrier. The subphase temperature
was maintained at 22 6 1C for lateral compression and x-ray scattering
experiments, and at 30 6 1C for insertion assays.
Epiﬂuorescence microscopy
The Langmuir trough used for insertion experiments was equipped with an
epiﬂuorescence microscope mounted to observe the phase morphology of
the lipid monolayer. The epiﬂuorescence microscopy techniques were
carried out as previously described (36,47–50). A resistively heated indium
tin-oxide-coated glass plate was placed over the trough to minimize
contamination and condensation on the microscope objective lens and to
minimize. Excitation between 530 and 590 nm and emission between 610
and 690 nm was gathered through the use of an HYQ Texas Red ﬁlter cube.
Lipid-linked Texas Red dye ((TR-DHPE) Molecular Probes, Eugene, OR;
0.5 mol %) was incorporated into the spreading phospholipid solutions. Due
to steric hindrance, the dye partitions into the disordered phase, rendering it
bright and the ordered phase dark. This assembly permits the monolayer
morphology to be observed over a large lateral area while isotherm data are
obtained concurrently.
GIXD and XR
Surface x-ray scattering experiments were carried out at the ID10B (Troı¨ka
II) beam line at the ESRF (Grenoble, France), and at the 9-ID (CMC-CAT)
beam line at the APS, Argonne National Laboratory (Argonne, IL). The
oxygen level was monitored as the vessel was ﬁlled with water-saturated
helium and was allowed to reach a sufﬁciently low level before measure-
ments were commenced (,0.1%). Water-saturated helium was used to
reduce evaporation and scattering from the air. Control measurements of
pure lipid monolayers were followed by subsequent injection of the desired
amount of peptide into the subphase under the monolayer-covered area of
the surface at 30 mN/m.
GIXD (51) was used to obtain in-plane information concerning the
molecular structure of surfaces (52). For GIXD measurements, the angle of
incidence (ai) was set to strike the air-aqueous interface at 0.8 ac, where ac is
the critical angle for total external reﬂection. A linear position-sensitive
detector that detected the diffracted beam recorded the intensity proﬁle as
a function of scattering angle. A Soller collimator with horizontal plates was
placed after the detector. Such a conﬁguration enables the incident wave to
be reﬂected, whereas the refractive wave propagates along the surface,
making this technique very sensitive to changes at the air-aqueous interface.
The incident wavelength used at the ESRF was 1.54 A˚, and the wavelength
at APS was 0.92 A˚.
Specular x-ray reﬂection measurements reveal information on the
electron-density distribution along the surface normal and may be used to
determine the density and thickness of thin layers (41,51,53). When specular
x-ray reﬂection occurs, the scattering vector qz may be calculated from
qz ¼ 4p sin a/l, where a is the grazing angle of the incident beam and
l the wavelength of the x-ray beam. When the reﬂectivity is measured as
a function of the scattering vector qz, the reﬂectivity curve contains
information regarding the gradient of the electron-density proﬁle in the
direction normal to the surface (54,55). XR measurements were carried
out over a range of angles corresponding to qz values of ;0–0.65 A˚
1.
A position-sensitive detector was used for detection and the reﬂected beam
intensity was measured as a function of the incident angle.
RESULTS AND DISCUSSION
Pressure-area compression isotherms
Pressure-area (p-A) isotherms are a traditional method for
the investigation of Langmuir monolayer phase behavior.
As the area decreases at constant temperature, any increase in
pressure on compression may be recorded.
Fig. 1 A shows typical p-A isotherms of DPPC, DPPE,
and DPPG that exhibit trends similar to those described in
earlier publications (35,50,56), as well as the p-A isotherm
of LL-37. As found from the Langmuir isotherm, the area per
DPPG molecule in a monolayer compressed at 30 mN/m is
45.6A˚2 and that for DPPC is 46.4A˚2 at the same pressure.
These values will be compared with area per molecule values
found from grazing incidence x-ray diffraction data.
Fig. 1 shows the surface pressure-area isotherm of an LL-
37 peptide. Contrary to insoluble amphiphilic molecules like
phospholipids, which are spread on an aqueous surface from
a chloroform solution, LL-37 is water-soluble and a peptide
surface ﬁlm is created via its absorption from the bulk sub-
phase at the interface after peptide injection into the DPBS
buffer. Since an increase in the surface pressure can be seen
with a decreased surface area, it is likely that the LL-37
aligns at the air-aqueous interface and is compressed slightly
to increase the surface pressure before collapse at;30 mN/m.
This is very similar to previous results for the PGLa peptide
(9,57), which is reported to adapt a-helical conformation.
Assuming that the LL-37 molecule is linear and a-helical in
shape (19,58,59), with the approximate helix diameter of the
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molecule being ;10 A˚ and a length of 1.5 A˚ per amino acid
residue (60), the molecular area of an LL-37 peptide may be
calculated to be in the region of A¼;550 A˚2 (assuming that
helix volume is based approximately on a cylindrical shape).
Constant-pressure insertion isotherms
Constant-pressure isotherm experiments involve compres-
sion of the monolayer to the desired pressure followed by
peptide injection into the subphase. Any increase or decrease
in the surface pressure from the setpoint after peptide in-
sertion will result in the compression or expansion of the
barrier(s) to advert the change. Increase in the surface pres-
sure value after injection is due to peptide insertion into the
lipid layer and will therefore result in barrier expansion.
Constant-pressure insertion isotherms show little or no
LL-37 insertion into DPPC and DPPE monolayers (Fig. 2, A
and B), whereas a substantial increase in DPPG area per
molecule indicates incorporation of peptide molecules into
the monolayer structure (Fig. 2, A and B). However, when
DPPG surface pressure is increased to 40 mN/m and peptide
is injected to reach a subphase concentration of 0.1 mg/ml
(Fig. 2 C), a critical destabilization of the monolayer takes
place.
Fig. 2 A illustrates the comparison of insertion results
using the lower concentration of LL-37 (0.04 mg/ml) at
constant pressures of 30 mN/m and 40 mN/m for DPPC,
DPPE, and DPPG monolayers, whereas Fig. 2 B contains
data for the higher concentration of LL-37 used (0.1 mg/ml).
The DPPG insertion isotherms (Fig. 2, A and B), indicate that
at 30 mN/m, increasing the concentration of the LL-37 by
2.5 times results in a subsequent fourfold increase in area per
DPPG molecule (Fig. 2 B). On the other hand, an increase of
LL-37 concentration in the subphase at the same pressure
does not result in any substantial area per molecule increase
FIGURE 1 Pressure-area isotherms of pure lipids DPPC (solid line),
DPPE (dashed line), and DPPG (dash-dotted line), and pure LL-37 peptide
(dotted line). LL-37 isotherm has been presented at a scale of one-ﬁfth of its
real area per molecule; pressure values are those actually recorded.
FIGURE 2 Insertion isotherms of DPPC and DPPG showing percent-
age change in area per molecule after injection of LL-37. (A) Systems at
concentration 0.04 mg/ml LL-37: DPPG 1 LL-37 at 30 mN/m (solid line);
DPPC 1 LL-37 at 30 mN/m (dashed line); DPPE 1 LL-37 at 30
mN/m (dotted line); DPPG 1 LL-37 at 40 mN/m (dash-dotted line). (B)
Systems at concentration 0.1 mg/ml LL-37: DPPG 1LL-37 at 30 mN/m
(solid line); DPPG 1 LL-37 at 40 mN/m (dashed line); DPPC 1 LL-37 at
30 mN/m (dotted line). (C) Critical destabilization of DPPG at 40 mN/m
after injection of 0.1 mg/ml LL-37 (dashed line). (Concentration values refer
to ﬁnal concentrations of peptide in solution.)
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in the DPPC monolayer (Fig. 2 B). From Fig. 2 A, it also
appears that LL-37 inserts into the DPPG monolayer to the
same ﬁnal extent at both 30 and 40 mN/m at the lower
concentration of LL-37, although the initial rate of insertion
is greater at 30 mN/m (Fig. 2 A).
When the peptide concentration reaches 0.1 mg/ml (Fig. 2
B), a pronounced difference is seen between the insertion
isotherms taken at 30 mN/m and those taken at 40 mN/m. A
very large increase in area (;180%) was seen on injection of
0.1 mg/ml LL-37 under the DPPG monolayer at 30 mN/m.
However, when the pressure of the system was kept at
40 mN/m, injection of the peptide resulted in insertion during
the ﬁrst 5–10 min and then a gradual decrease in area to
a value below that seen before the introduction of the peptide
(Fig. 2 C). This effect is very similar to that of introducing
the porcine PG-1 peptide into a lipid A system at 35 mN/m
(35). It is likely that at this higher concentration and pressure,
a critical threshold has been reached, resulting in a critical
destabilization of the DPPG monolayer. This result is con-
sistent with permeabilization of the bacterial membrane by
LL-37 via the ‘‘carpet’’ route, which involves a threshold con-
centration of peptide to carpet the membrane before any pore
formation can occur.
Epiﬂuorescence
EFMmeasurements were performed simultaneously with the
insertion isotherms to monitor the effect of peptide binding
on the morphology of the monolayer. Fluorescence image
contrast arises due to different phase densities and partition-
ing characteristics of the dye molecules in coexisting phases.
Therefore, it is possible to gain insight into the structure of
the lipid layer by imaging its lateral ﬂuorescence distribu-
tion.
EFM images of the pure lipid monolayers at both 30 and
40 mN/m display an array of very densely packed ‘‘dark gray’’
domains of condensed phase with narrow, ‘‘light gray’’
liquid-phase borders between them. Little or no change in
DPPE and DPPC morphology was observed after injection
of LL-37 at either 0.04- or 0.1-mg/ml concentration (Fig. 3, A
and C). A very slight increase in the amount of bright dis-
ordered phase of DPPC at the higher peptide concentration
was observed after 19 min (Fig. 3 C3).
In contrast, DPPG displays profound changes at both
pressures and concentrations of LL-37 used (Fig. 4). At
30 mN/m, with injection of the lower concentration of LL-37
(Fig. 4 A), a signiﬁcant increase in the area of bright disor-
dered phase and a decrease in the dark condensed-phase area
can be seen, indicating substantial insertion of the peptide
into the disordered phase of the monolayer. After only 3 min
(Fig. 4 A3), large regions of disordered lipid phase appeared,
and this quickly developed into a structure in which the
majority of the lipid domains present were disordered and the
remaining condensed phase dissipates into a ‘‘web-like’’
structure (Fig. 4 A5). When LL-37 was injected under the
DPPGmonolayer at 30 mN/m to give a ﬁnal concentration of
0.1 mg/ml (Fig. 4 B), there ws an immediately noticeable
difference in the epiﬂuorescence images. The image taken
before LL-37 injection (Fig. 4 B1) shows clear separation of
the condensed and disordered phases. Immediately after
FIGURE 3 Epiﬂuorescence images
of systems at 30 mN/m. (A1) DPPE
monolayer at 30 mN/m before injec-
tion. (A2) DPPE monolayer 1 min after
0.04 mg/ml LL-37 injection. (A3) DPPE
monolayer 2 min after 0.04 mg/ml LL-37
injection. (B1) DPPC monolayer at 30
mN/m before injection. (B2) DPPCmono-
layer 1 min after 0.04 mg/ml LL-37 in-
jection. (B3) DPPC monolayer 6 min
after 0.04 mg/ml LL-37 injection. (C1)
DPPC monolayer at 30 mN/m before
injection. (C2) DPPC monolayer 18 min
after 0.1 mg/ml LL-37 injection. (C3)
DPPC monolayer 19 min after 0.1 mg/ml
LL-37 injection. (Concentration values
0.04 mg/ml and 0.1 mg/ml refer to ﬁnal
concentrations of peptide in solution.)
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introduction of LL-37 (Fig. 4 B2), it is clear that the domain
edge becomes fuzzy, most likely due to the high speed of
insertion of the LL-37 into the monolayer and the use of the
domain edge as the preferred location for insertion.
When the DPPG system was studied at the higher constant
pressure of 40 mN/m, quite a different pattern of insertion
was observed. The images before injection of LL-37 at either
concentration of LL-37 demonstrate what seems to be a more
closely packed layer, with clearly deﬁned regions of con-
densed and disordered phase domains, due to the fact the
monolayer is further compressed at 40 mN/m. After injection
of 0.04 mg/ml LL-37, regions of bright disordered phase
quickly appear (Fig. 5 A2). After 10 min (Fig. 5 A5), the
monolayer is already mostly disordered by the LL-37 in-
sertion and condensed-phase dark regions are indistinct.
When the higher concentration of LL-37 was injected under
the DPPG monolayer at 40 mN/m (Fig. 5 B), the disordered
phase grew larger whereas the size of the condensed-phase
domains decreased. Nevertheless, distinct condensed-phase
domains were clearly visible even half an hour after peptide
injection (Fig. 5 B4). At the next stage of the ﬁlm evolution,
solid domains shrunk further with the phase separation border
becoming clearly blurred (Fig. 5 B5), not unlike Fig. 5 A6.
At this stage (see insertion isotherm at Fig. 2 B), the ﬁlm
was slowly disintegrating and at 1.5 h after peptide insertion
not only had the condensed phase disappeared, but new,
spontaneously-formed, small bright domains were visible at
places formerly occupied by solid domains (Fig. 5 B6). It is
possible that the peptide insertion causes the lipid to form
some kind of self-assembled structure that combines both the
lipid and the peptide. This suggests that the DPPG monolayer
is destabilized due to the fact that it has been saturated with
LL-37, which agrees with the ‘‘carpet’’ mechanism of LL-37
interaction with DPPG at this concentration and surface
pressure.
Grazing incidence x-ray diffraction
Grazing incidence x-ray diffraction measurements are made
with the x-ray momentum transfer in or close to the plane of
the air-aqueous interface. The reﬂections of the Bragg peaks
observed with this geometry can be indexed by two Miller
indices, hk. Their angular positions 2uhk, corresponding to
qhk ¼ (4p/l)sinuhk, yield the repeat distances dhk ¼ 2p/qhk
for the two-dimensional lattice structure (40,55).
GIXD was performed in conjunction with insertion iso-
therms (not shown here but similar to those taken with ﬂuo-
rescence experiments) to monitor the effect of peptide
insertion on the molecular packing of the lipid monolayers of
different compositions. Bragg peak proﬁles (intensity against
qxy) were ﬁtted with Gaussians and the peak position values
were used to obtain unit-cell dimensions of the lipid lattices,
whereas full-width half-maximum values of the peaks were
used to determine the coherence length from the Scherrer
formula, L ¼ 0.9 3 2p/full-width half-maximum (qxy)
(61,62). Bragg rod proﬁles were measured at Bragg peak
positions. Bragg rod proﬁles were analyzed to determine the
tilt of the hydrocarbon chains (52).
The observation of two Bragg peaks in the diffraction
pattern of an amphiphilic monolayer is indicative of a dis-
torted hexagonal unit cell (which can be viewed as centered
rectangular). Therefore, all unit-cell dimensions in this study
FIGURE 4 (A1) DPPG monolayer at
30 mN/m before injection and at 2 min
(A2), 3 min (A3), 4 min (A4), 10 min
(A5), and 20 min (A6) after LL-37 injec-
tion. (B1) DPPG monolayer at 30 mN/m
before injection and at 4 min (B2) and 7
min (B3) after 0.1 mg/ml LL-37 injection.
(Concentration values refer to ﬁnal con-
centrations of peptide in solution.)
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were calculated using the centered rectangular unit-cell ap-
proximation.
GIXD—DPPC
Pure DPPC monolayer data (Fig. 6 A1) show two Bragg
peaks corresponding to d-spacings of 4.60 A˚ and 4.26 A˚.
This translates to a centered rectangular unit cell with di-
mensions of a ¼ 5.47 A˚ and b ¼ 8.53 A˚ and an area per
DPPC molecule of A ¼ 46.6 A˚2, as each unit cell contains
two hydrocarbon chain components of the phospholipid
molecule. This area per molecule value agrees well with that
obtained from the pressure-area isotherm (Fig. 1) and those
obtained in previous studies (9,54,57,63–65). The coherence
lengths, calculated with the Scherrer formula (52,62), give
values of ;126 A˚ and 1061 A˚ for the {1,1} (L11) and {0,2}
(L02) reﬂections, respectively. Analysis of Bragg rod proﬁle
yields a molecular tilt of 30 for the lipid molecules in the
condensed phase. These values are again very close to those
obtained by other authors (9,54,57,63–65). The area per
molecule obtained from GIXD data is valid only for the
ordered part of the monolayer. The fact that the area per
molecule from the p-A isotherm corresponds to values
obtained from GIXD indicates that the monolayer is mostly
ordered, corroborating our EFM observations.
Fig. 6 A2 shows a slight change in DPPC packing after
LL-37 injection at a constant pressure of 30 mN/m. Here,
the second peak position shifts only very slightly,yielding
d-spacings of 4.64 and 4.27 A˚. This computes to unit-cell
dimensions of a ¼ 5.52 A˚ and b ¼ 8.54 A˚ and an area per
molecule of A ¼ 47.1 A˚2, showing little interaction of LL-37
with the phosphatidylcholine headgroup. The coherence
lengths changed only slightly from the DPPC monolayer
alone, to L11 ¼ 128 A˚ and L02 ¼ 1193 A˚. The calculated
molecular tilt value did not change and was 30 after the
injection of LL-37. This again is corroborated by the inser-
tion isotherms and epiﬂuorescence data (Figs. 2–5), which
also show little change in lipid packing.
GIXD—DPPG
Pure DPPG at 30 mN/m (Fig. 6 B1) yields two peaks corre-
sponding to d-spacings of 4.51 A˚ and 4.25 A˚, centered-
rectangular unit-cell dimensions of a¼ 5.32 A˚ and b¼ 8.51 A˚,
and an area per molecule ofA¼ 45.2 A˚2. This value is again in
good agreement with that obtained using the area-pressure
compression isotherm and with previously published GIXD
results (9,35,57). The coherence lengths for aDPPGmonolayer
at 30 mN/m are calculated to be L11¼ 75 A˚ and L02¼ 448 A˚.
The molecular tilt is found to be 27 for the DPPG monolayer.
FIGURE 5 Epiﬂuorescence images of
DPPG1 LL-37 at 40 mN/m. (A1) DPPG
monolayer at 40 mN/m before injection,
and at 3 min (A2), 6 min (A3),7 min (A4),
10 min (A5), and 13 min (A6) after
0.04 mg/ml LL-37 injection. (B1) DPPG
monolayer at 40 mN/m before injection
and at 8 min (B2), 14 min (B3), 31 min
(B4), 63 min (B5), and 92 min (B6) after
0.1 mg/ml LL-37 injection. (Concentra-
tion values 0.04 mg/ml and 0.1 mg/ml
refer to ﬁnal concentrations of peptide in
solution.)
LL-37 Membrane Interactions 1281
Biophysical Journal 90(4) 1275–1287
After LL-37 insertion, no Bragg peaks or rods were ob-
served, indicating that the ordered structure of the DPPG
monolayer has been totally disrupted by LL-37 (Fig. 6 B2).
This is again conﬁrmed by insertion isotherms (Fig. 2) and
epiﬂuorescence data (Fig. 4), which show increases in area
per molecule and an increased area fraction of the disordered
bright phase, respectively, demonstrating disruption of the
membrane by the peptide. For easy comparison of the GIXD
data, results for both the DPPC and DPPC lipid systems are
shown in Table 1.
X-ray reﬂectivity
Specular x-ray reﬂection measurements record the intensity
of those x-rays scattered from the air-aqueous interface with
a momentum transfer strictly perpendicular to the interface.
The structure factor associated with the XR proﬁle is de-
termined by the Fourier transform of the gradient of the
electron density perpendicular to the interface. The data
cannot in general be uniquely inverted to yield the electron-
density proﬁle (66). It is a common practice for XR data to be
ﬁtted to a model of the interface consisting of a stack of
uniform slabs, each with a different electron density ri and
thickness Li (40,66–69). For example, each lipid molecule
may be modeled with two slabs, corresponding to the head
and tail regions of the molecule, with different electron
densities and thicknesses. The effect of capillary waves on
the density distribution in the interface is modeled by a
Gaussian roughness, s. The XR data were analyzed with
RFit2000 (70–74), which uses elements of global minimi-
zation (75) to calculate the reﬂectivity based on the Parrat
method (76).
XR—DPPC
Fig. 7 A shows the reﬂectivity curve normalized to the
Fresnel reﬂectivity of a planar interface of the subphase (R/
RF) against the scattering vector (q) in the z direction (qz) for
the DPPC monolayer at 30 mN/m before and after injection
of LL-37 into the subphase. It shows the measured ex-
perimental data obtained and the calculated least-square
ﬁtted model. Successful ﬁts to the data demonstrated that the
DPPC monolayer may be modeled as two slabs with dif-
ferent thicknesses and electron densities. The thickness of
FIGURE 6 Bragg peak/rod combination plot of
scattering vectors qxy and qz as a function of their
respective intensities. (A) DPPC monolayer at 30
mN/m. (B) DPPC monolayer at 30 mN/m after
0.04 mg/ml LL-37 injection into the subphase. (C)
DPPG monolayer at 30 mN/m. (D) DPPG mono-
layer at 30 mN/m after 0.04 mg/ml LL-37 injection
into the subphase. The initial Bragg peaks from
scattering of ordered structure of the monolayer
vanish upon LL-37 insertion into the DPPG
monolayer, whereas the DPPC monolayer was left
practically unchanged. (Concentration values 0.04
mg/ml and 0.1mg/ml refer to ﬁnal concentrations of
peptide in solution.)
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the tail layer was found to be 15.2 A˚ and the headgroup layer
thickness 8.8 A˚, with tail- and head-layer electron-density
values (normalized to the electron density of the subphase) of
0.91 and 1.33, respectively. The roughness of the layers was
found to be 3.3 A˚. These values agree well with previously
published values (54,63,68).
In addition to the insertion, epiﬂuorescence, and GIXD
results, the XR data also show little difference in the DPPC
monolayer electron-density proﬁle after LL-37 injection.
The data of the DPPC/LL-37 system was again modeled with
two slabs. Two different concentrations of LL-37 were used
in these experiments: 0.04 mg/ml and 0.1 mg/ml. The DPPC
1 0.04 mg/ml LL-37 data yielded a tail thickness of 16.2 A˚
and a head-layer thickness of 8.2 A˚. The normalized tail and
head electron-density values were 0.95 and 1.38, respectively,
and a molecular roughness between layers was determined to
be 3.5 A˚. The ﬁt to the data of the system where 0.1 mg/ml
LL-37 was injected under the DPPC monolayer gave values
similar to those presented above. The tail layer was found to
be 16.5 A˚ thick, with a normalized electron density of 0.95,
and the head layer was 6.9 A˚ thick, with a density of 1.39.
Both layers had a roughness value of 3.5 A˚.
XR—DPPG
The R/RF plot in Fig. 7 B shows the DPPG data obtained at
30 mN/m. The best ﬁt was again obtained using two slabs, as
with DPPC, yielding 18.1 A˚ for the tail layer thickness and
5.9 A˚ for the headgroup layer thickness. The normalized
electron-density values for the tail and headgroup layers
were 0.98 and 1.55, respectively, with a roughness value of
3.7 A˚ for both. These results are in line with previous results
(35,77), with small differences most likely attributable to the
use of different subphases.
Fig. 7 B shows substantial change in the reﬂectivity proﬁle
upon injection of LL-37 under the DPPG monolayer at 30
mN/m. Since the minima that are observable in R/RF plots
are due to interference of x-ray waves reﬂected from the
interfaces of the slabs in the surface layer, the minima are
characteristic of the thickness of the lipid monolayer. After
injection of 0.04 mg/ml LL-37, the XR proﬁle is very dif-
ferent from that of the DPPG monolayer alone, with the
minimum of the curve being shifted to a greater qz value by
;0.11 A˚1. This indicates a decrease in monolayer thickness,
similar to that observed by Huang et al. (78). Although the
amplitude of the second peak was reduced, it was possible to
ﬁt the data using a two-slab model (Fig. 8). The top slab has
been modeled as the lipid tailgroups, with peptide inserted
slightly into the hydrocarbon tail region, and the second slab
has been modeled as a mix of headgroups and peptide. The
least-square ﬁt parameters gave 7.4 A˚ for the thickness of the
top layer (the layer closest to the air), with a normalized
electron density of 1.23, and 8.1 A˚ for the thickness of the
second layer, with a density of 1.33. The roughness obtained
was 5.6 A˚. The results of the ﬁtting suggest that the peptide
has penetrated the headgroup region, as the electron density
has decreased by ;17%. It is clearly seen that the peptide
has also partially penetrated into the tail region, destabilizing
it, as its electron density has increased by ;26%. All the
results of the XR data ﬁtting are presented in Table 2 for
clarity.
Complementary data from insertion experiments, epi-
ﬂuorescence measurements, and x-ray scattering allow us to
speculate as to how the LL-37 peptide differentiates between
different model membranes. The data analysis suggests that
there is little interaction of LL-37 with DPPC and DPPE
monolayers, but distinct interaction with DPPG monolayers.
Fig. 8 shows a schematic cartoon of the proposed mode of
interaction of LL-37 with DPPG monolayers at 30 mN/m
based on results from the EFM and x-ray data. The DPPG
monolayer has a tightly packed ordered structure at 30 mN/
m, which, after injection of LL-37 into the subphase, is
disturbed as the peptide penetrates the DPPG monolayer.
Some regions of ordered lipid structure may remain, but
the magnitude of peptide interaction and possible movement
of the lipid molecules to accommodate the peptide in the
monolayer have a great effect, resulting in the overall thin-
ning of the ﬁlm. The change in monolayer morphology after
peptide insertion was monitored with epiﬂuorescence (Fig.
4), whereas the change in ﬁlm thickness was obtained from
XR data modeling. Our results suggest that it is highly likely
that the peptide penetrates the lipid monolayer, lying parallel
to the surface. Thus the inserted peptides carpet the lipid
monolayer, in agreement with Y. Shai and colleagues’
‘‘carpet’’ mechanism of action of antimicrobial peptides
(11,22). Since our study uses monolayers, it is not possible
to know whether this could later lead to the formation of
toroidal pores in bilayer systems. Therefore, this work is
TABLE 1 Grazing incidence x-ray diffraction data for systems at 30 mN/m, 22C
Coherence length (A˚)
Experiment d11 (A˚) d02 (A˚) a (A˚) b (A˚) Area per molecule (A˚
2) Tilt angle () L11 L02
DPPC 4.60 4.26 5.47 8.53 46.6 30 ;126 ;1061
DPPC 1 0.04 mg/ml LL-37 4.64 4.27 5.52 8.54 47.1 30 ;128 ;1193
DPPG 4.51 4.25 5.32 8.51 45.2 27 ;75 ;448
DPPG 1 0.04 mg/ml LL-37 No peaks visible NA NA
‘‘11’’ and ‘‘02’’ are used to denote hk for a set of Bragg rods with equal in-plane components, which cannot be resolved from the GIXD data. In this case, data
are calculated using the rectangular unit cell, thus f11g lattice means f(11), (1 1), ( 1 1), (1 1)g and f02g means f(02), (0 2)g.
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presented as an important but complementary approach to
studies involving live cells, vesicles, and bilayers.
XR—LL-37
X-ray reﬂectivity data for LL-37 (Fig. 7 C) show slight
differences in the structure of the ﬁlm when the pressure was
increased from 0 to 28 mN/m. A small increase in layer
thickness was observed between these two pressures,
suggesting that the LL-37 molecules become more tightly
packed after the ﬁlm compression and thus the molecular
rearrangement produces a thickening of the peptide layer.
Moreover, XR analysis indicates a second partial layer of
LL-37 forming underneath the top layer. XR data at 0 mN/m
was modeled as a one-slab model with an electron density
normalized to the electron density of the subphase of 1.18
and a thickness of L¼ 7.7 A˚. This suggests that LL-37 aligns
at the air-liquid interface with the molecules oriented parallel
to the surface. XR data at p ¼ 28 mN/m can no longer be
ﬁtted with a single slab and it was necessary to use a two-slab
model. It is most likely that at 28 mN/m there is not enough
space for every LL-37 molecule to align at the surface in the
same way as at 0 mN/m, so some molecules would get forced
out from a single layer to make a partial second layer. The
ﬁtting of the data using a two-slab model returned values of
L1¼ 8.5 A˚ and L2¼ 4.3 A˚ for the two layers (going from the
air-liquid interface toward the subphase). Corresponding
normalized density values for the layers were 1.13 and 0.96,
which could correspond to an upper layer and a partial second
layer consisting of some peptide molecules that might be
partly in the upper layer, with the more hydrophilic regions
extending into the subphase. The fact that the LL-37 XR data
do not show deﬁned structural features, such as those seen
for lipids like DPPC and DPPG, suggests that the LL-37
peptide layer is somewhat amorphous, as is seen with other
protein structures at the air-liquid interface (9,79). This is
corroborated by GIXD data (not shown), which show no
Bragg peaks at either pressure (0 or 28 mN/m) and thus
FIGURE 7 Reﬂectivity data and corresponding ﬁts normalized by Fresnel
reﬂectivity plotted against scattering vector (qz). (A) DPPC monolayer
reﬂectivity data (square) and ﬁt (solid line), DPPC after 0.04 mg/ml LL-37
injection, and data (circle) and ﬁt (dashed line) 0.1 min after 0.04 mg/ml LL-
37 injection; (A4) 7 min after 0.04 mg/ml LL-37 injection; and (A5) 10 min
after 0.04 mg/ml LL-37 injection. (A6) DPPG monolayer 13 min after 0.04
mg/ml LL-37 injection. (B1) DPPG monolayer at 40 mN/m before injection
and at 8 min (B2), 14 min (B3), 31 min (B4), 63 min (B5), and 92 min (B6)
after 0.1 mg/ml LL-37 injection. (Concentration values 0.04 mg/ml and
0.1 mg/ml refer to ﬁnal concentrations of peptide in solution.)
FIGURE 8 Cartoon schematic of possible interactions of LL-37 with
bacterial membranes. (A) DPPG. (B) DPPG after insertion of LL-37. Cartoon
based on x-ray data (GIXD and XR).
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demonstrate that LL-37 does not show long-range lateral
two-dimensional structure at the air-aqueous interface.
CONCLUSIONS
This is the ﬁrst study we know of in which x-ray reﬂectivity
and grazing incidence x-ray diffraction were used to observe
the effects of the antimicrobial peptide LL-37 on phospho-
lipid monolayers at the air-liquid interface. Moreover, syn-
chrotron surface x-ray scattering has been combined with
epiﬂuorescence microscopy to give a further insight into the
interactions of LL-37 with lipid monolayers.
GIXD experiments show that there is very little change
in the phosphatidylcholine lipid packing upon addition of
LL-37 to the subphase. This indicates that there is no detri-
mental interaction between the human antimicrobial peptide
and the DPPC monolayer at the concentrations used here,
contradicting the results of Oren et al. (19) and Henzler-
Wildman et al. (26), who observed LL-37 lytic activity
toward human red blood cell membrane mimics. However,
our working peptide concentrations of 0.04 mg/ml (9 nM)
and 0.1 mg/ml (22 nM) were signiﬁcantly lower, and it is
entirely possible that with an increase of LL-37 concentra-
tion to MIC levels (1–10 mM) we would observe peptide
insertion into DPPC. This is in stark contrast to the DPPG
monolayer, whose structure is completely destroyed after in-
jection of LL-37. These results agree well with insertion
assay and epiﬂuorescence data, which show LL-37 insertion
into DPPG, but not into DPPC, ﬁlms.
The GIXD data obtained from the LL-37 peptide alone
reveal that it does not form an ordered two-dimensional
crystalline structure at the air-aqueous interface although it is
able to form a ﬁlm at the surface, as demonstrated by the
pressure-area isotherms carried out with the peptide. XR data
of the peptide alone corroborate the GIXD ﬁndings, sug-
gesting that the peptidemolecules self-assemble in-planewith
the surface, forming layers of approximately the thickness
expected for an a-helical peptide. These results prove very
useful in suggesting a proposed model for the lipid-peptide
interactions of the bacterial membrane with LL-37.
As expected, the x-ray reﬂectivity model ﬁts suggest that
the DPPC monolayers show little change after addition of the
LL-37 to the subphase. Even increasing the concentration of
the peptide by 2.5 times the original concentration makes
little difference in the results obtained. However, the XR data
of the DPPG/LL-37 system suggest that LL-37 molecules
penetrate in-plane with the monolayer and insert predomi-
nantly into the phospholipid headgroup region, partitioning
the peptide partly into the hydrocarbon tail region. The
peptide/lipid ratio at the interface can be calculated analyzing
insertion isotherms and x-ray reﬂectivity data. The insertion
isotherm yields an area per lipid molecule increase caused by
peptide absorption at the interface, whereas x-ray reﬂectivity
yields the thickness of the peptide layer, and, thus, the
peptide insertion angle. For DPPG at 30 mN/m this gives us
a lipid/peptide ratio of 28:1 for peptide concentrations of
0.04 mg/ml and 6:1 for those of 0.1 mg/ml.
This is in agreement with recent work using other tech-
niques (25,26,36), which proposes that the peptide carpets
bacterial membranes. The work presented here also suggests
that the LL-37 carpets the outside of the membrane before
complete membrane disruption.
In summary, the research presented here used Langmuir-
trough-generated lipid monolayers to investigate the lipid
discrimination of LL-37 and its mechanism of action. By
coupling synchrotron x-ray scattering and epiﬂuorescence
microscopy techniques with the use of Langmuir ﬁlms, the
interactions of LL-37 with phospholipid monolayers can be
directly examined. Our results suggest that LL-37 can dif-
ferentiate between eukaryotic and bacterial cell membrane
lipid types. This work also supports previous work sug-
gesting that the human antimicrobial peptide LL-37 acts
against bacterial membranes via the ‘‘carpet’’ mechanism of
membrane perturbation. The knowledge of the discrimina-
tion of LL-37 for different cell types and its mechanism of
action bodes well for the production of future pharmaceutical
therapeutic agents in the ongoing battle against antibiotic-
resistant bacterial disease.
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TABLE 2 X-ray reﬂectivity ﬁtting data for systems at 30 mN/m, 22C
Experiment L1 (A˚) r1/rDPBS L2 (A˚) r2/rDPBS Roughness s (A˚)
DPPC 15.2 0.91 8.8 1.33 3.3
DPPC 1 0.04 mg/ml LL-37 16.2 0.95 8.2 1.38 3.5
DPPC 1 0.1 mg/ml LL-37 16.5 0.95 6.9 1.39 3.5
DPPG 18.1 0.98 5.9 1.55 3.7
DPPG 1 0.04 mg/ml LL-37 7.4 1.23 8.1 1.33 5.6
L1 refers to the slab modeled to be between the air and the L2 slab, and L2 refers to the layer modeled between the top layer (L1) and the aqueous subphase.
r1 and r2 are the respective electron densities of these layers. Electron-density values are normalized by the electron-density value of the DPBS subphase
(0.337 e/A˚3). Data show a comparison of systems before and after the addition of LL-37. Very little difference was seen upon addition of LL-37 to the
DPPC system, even with increasing concentration, whereas a signiﬁcant difference was seen when LL-37 was injected under the DPPG monolayer, even
at the lower of the two concentrations used with DPPC.
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